|Sample-dependent, check data in validation data gallery|
19791-1-AP targets BRCA2 in WB, IHC, ELISA applications and shows reactivity with human samples.
|Host / Isotype||Rabbit / IgG|
|Full Name||breast cancer 2, early onset|
|Calculated molecular weight||384 kDa|
|GenBank accession number||NM_000059|
|Gene ID (NCBI)||675|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
BRCA2, also named as FACD and FANCD1, is involved in double-strand break repair and/or homologous recombination. BRCA2 may participate in S phase checkpoint activation. Defects in BRCA2 are a cause of genetic susceptibility to breast cancer (BC) which also called susceptibility to familial breast-ovarian cancer type 2 (BROVCA2).
J Hematol Oncol
SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Ann Transl Med
miR-1245a promotes the proliferation and invasion of colon adenocarcinoma by targeting BRCA2.
Cell Death Dis
FDI-6 inhibits the expression and function of FOXM1 to sensitize BRCA-proficient triple-negative breast cancer cells to Olaparib by regulating cell cycle progression and DNA damage repair.
Cancer Biol Ther
A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy.
Flavone protects HBE cells from DNA double-strand breaks caused by PM2.5.
DNA repair gene expression is increased in HPV positive head and neck squamous cell carcinomas.